Navigation Links
EXAMINE-Studie zur kardiovaskulären Sicherheit von Alogliptin erreicht primären Endpunkt: keine Erhöhung des kardiovaskulären Risikos bei Risikopatienten mit Typ-2 Diabetes
Date:9/11/2013

mprop="name">von Takeda, einschließlich der allgemeinen wirtschaftlichen Lage in Japan, den Vereinigten Staaten und weltweit; (2) Wettbewerbsdruck und Wettbewerbsentwicklungen; (3) geltende Gesetze und Vorschriften; (4) der Erfolg oder Misserfolg von Produktentwicklungsprogrammen; (5) Handlungen von Behörden und deren jeweiliger Zeitpunkt; (6) Veränderungen der Wechselkurse; (7) Beanstandungen oder Sorgen hinsichtlich der Sicherheit oder Wirksamkeit vermarkteter Produkte oder Produktkandidaten in der Entwicklung; und (8) Aktivitäten der Integration akquirierter Unternehmen.

Die in dieser Pressemitteilung enthaltenen zukunftsbezogenen Aussagen gelten nur für den Zeitpunkt dieser Pressemitteilung, und Takeda verpflichtet sich nicht, zukunftsbezogene Aussagen zu überarbeiten oder zu aktualisieren, um neue Informationen, künftige Ereignisse oder Umstände nach dem Zeitpunkt der zukunftsbezogenen Aussage zu reflektieren. Wenn Takeda eine oder mehrere dieser Aussagen aktualisiert oder korrigiert, dürfen Investoren und andere nicht daraus schließen, dass Takeda weitere Aktualisierungen oder Korrekturen vornimmt.


'/>"/>
SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. American College of Chest Physicians (ACCP) und Simbionix arbeiten zusammen, um klinische Ausbildung und Patientensicherheit zu verbessern
2. Messe/Konferenz InnoPack Pharma legt den Fokus auf innovative Verpackungen für Compliance und Sicherheit
3. Takeda EXAMINE Cardiovascular Safety Outcomes Trial of Alogliptin Met Primary Endpoint of Non-Inferiority Compared to Placebo in Addition to Standard of Care Showing No Increase in Cardiovascular Risk in Type 2 Diabetes Patients at High-Risk for Car
4. Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States
5. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
6. Takeda Resubmits New Drug Applications to the United States Food and Drug Administration for Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone
7. National Diabetes Volunteer Leadership Council (NDVLC) Urges FDA to Enforce Stringent Accuracy Standards for Blood Glucose Monitoring Systems
8. Clinilabs Sponsors The ADAs 2013 Step Out: Walk to Stop Diabetes
9. GSMA mHealth Grand Tour Highlights How Mobile Technology Could Help Prevent 5 Million People In The EU From Developing Diabetes
10. Elcelyx Therapeutics NewMet for Type 2 Diabetes Meets Primary Endpoint in Phase 2b Study
11. Bio-Solutions Corp. Expanding in Booming Diabetes Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... 21. April 2015  CorTechs Labs, der ... Analyse des Hirnvolumens freut sich, eine Partnerschaft ... bekannt geben zu können. Die Unternehmen werden ... Hirnvolumens zusammenarbeiten, der die Identifizierung, Messung und ... mit multipler Sklerose als Ziel hat. ...
(Date:4/21/2015)... , April 21, 2015 Gary A. ... National Minority Quality Forum (NMQF), today will present ... the Pharmaceutical Research and Manufacturers of America ... clinical trials. On behalf of PhRMA, and in conjunction ... campaign to build awareness, start conversations, and increase diversity ...
(Date:4/21/2015)... LOS ANGELES , April 21, 2015 ... symptomatic uterine fibroids known as the Acessa™ procedure is ... Southern California women aged 25-55 who ... Lee , MD, FACOG, the inventor and world,s leading ... to hysterectomy and myomectomy, has helped establish two new ...
Breaking Medicine Technology:CorTechs Labs kündigt Partnerschaft für die Bereitstellung umfassender Lösungen zur Quantifizierung des Verlustes von Hirnvolumen bei multipler Sklerose an 2National Minority Quality Forum to Award PhRMA President John Castellani for Leadership in Increasing Clinical Trial Diversity 2National Minority Quality Forum to Award PhRMA President John Castellani for Leadership in Increasing Clinical Trial Diversity 3New Minimally Invasive Treatment for Uterine Fibroids Offers Life-Changing Relief, Without a Hysterectomy, to 1 Million Southern California Women 2New Minimally Invasive Treatment for Uterine Fibroids Offers Life-Changing Relief, Without a Hysterectomy, to 1 Million Southern California Women 3New Minimally Invasive Treatment for Uterine Fibroids Offers Life-Changing Relief, Without a Hysterectomy, to 1 Million Southern California Women 4
(Date:4/21/2015)... Dallas, Texas (PRWEB) April 21, 2015 ... Review, H1 2015” provides comparative analysis on ... strengthens R&D pipelines by identifying new targets ... products. Complete report with TOC is available ... report also reviews key players involved in ...
(Date:4/21/2015)... April 21, 2015 Information is the best ... Ryan, MD, FACP, empowers patients and their families with knowledge ... the Rumor and Cancer is the Answer" and new ... informative language to guide patients from diagnosis through treatment and ... active participants in their treatment, at home and in the ...
(Date:4/21/2015)... Spokane, WA (PRWEB) April 21, 2015 ... Medical Practice Edition 2 for otolaryngologists, bringing the ... in the healthcare community. Otolaryngologists can now ... backed by a trusted source in the industry, ... successful integration with leading EHRs. , “Lyft is ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 On April ... Awards” EcoLuxe Lounge at the world famous Avalon Hollywood. ... sustainable product placement in TV and film, the EcoLuxe ... appearances at many awards ceremonies and festivals throughout the ... providers of eco-friendly and socially conscious products and services, ...
(Date:4/21/2015)... April 21, 2015 This year, in ... Skin Types, Inc.® (FIRST) will publish a unique awareness ... will run throughout the month of May and carry ... to Someone." The positioning was chosen to encourage ... skin disorder and to help support our mission of ...
Breaking Medicine News(10 mins):Health News:Sinusitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Sinusitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Authoritative guide and new accompanying therapeutic web portal bridge information gaps in cancer treatment 2Health News:Lyft Expands Its Offerings to Include Dragon® Medical Practice Edition 2 for Otolaryngologists. 2Health News:Hollywood's Santana Dempsey and Choices Recovery South Bend Examine Victory over Personal Struggles 2Health News:May is Ichthyosis Awareness Month. Use Your Voice. 2
... stand up for America,s small,businesses., WASHINGTON, June ... the Democratic National Committee:, (Logo: http://www.newscom.com/cgi-bin/prnh/20080519/DNCLOGO ... stand up for America,s small businesses and,that "[e]ntrepreneurs ... and,prosperity." But in reality as president Senator McCain,s ...
... Partner to Provide Solution to Teaching Hospital ... Serving Fourth Largest Population Center, ... Bulletin Board: GLOB), an international e-Health, medical,information technology company, ... agreement to license its SafeTrace,Tx(R) transfusion management software to ...
... Blue Cross and Blue Shield,of Florida, Inc., (BCBSF) ... in Florida," for the second year in a ... National Health Insurance,Plan Study(SM)., (Logo: http://www.newscom.com/cgi-bin/prnh/20000427/BLUELOGOA ... BCBSF received the highest numerical score in ...
... Tips from an Expert in Making Fatherhood Happen, ... data indicate that Georgia had 149,919 new babies born ... obviously, not only,were there many thousands of new mothers, ... "If you,re thinking about becoming a father for the ...
... UK: Researchers are harnessing the powers of digital ... manage the side-effects caused by chemotherapy. , They ... mobile phones on which the patients can record and ... professionals managing their care. The phones are capable of ...
... discovered a new way to reduce neuronal loss in the ... loss in people with Alzheimer,s disease can be attributed to ... neuro-toxin Amyloid beta the major component of amyloid plaques ... a specific population of nerve cells in the basal forebrain. ...
Cached Medicine News:Health News:Democratic National Committee McCain Myth Buster: John McCain and America's Small Businesses 2Health News:Democratic National Committee McCain Myth Buster: John McCain and America's Small Businesses 3Health News:Global Med Technologies(R) Signs Agreement With California's Century Old Riverside County Regional Medical Center 2Health News:Global Med Technologies(R) Signs Agreement With California's Century Old Riverside County Regional Medical Center 3Health News:Blue Cross and Blue Shield of Florida Awarded Prestigious J.D. Power and Associates Award for Second Year 2Health News:Thinking About Being a Father? 2Health News:Managing symptoms by mobile phone may revolutionize cancer care for young people 2Health News:Managing symptoms by mobile phone may revolutionize cancer care for young people 3Health News:QBI neuroscientists make Alzheimer's disease advance 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: